Share Price:

APNASPENAspen Pharmacare Hldgs15105397 (2.70%)

Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

Developing future capability starts with investing in people

Screenshot

That commitment was recently brought to life through the participation of our Group Regulatory Specialist, Nabila Essack, in an international training and development programme focused on vaccine manufacturing and regulation.

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: